Teladoc Health [TDOC] vs Ge Healthcare [GEHC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Teladoc Health Inc. wins in 6 metrics, Ge Healthcare Technologies Inc. wins in 12 metrics, with 0 ties. Ge Healthcare Technologies Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Teladoc Health Inc. | Ge Healthcare Technologies Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 15.92 | N/A |
| Price-to-Book Ratio | 0.74 | 3.18 | Teladoc Health Inc. |
| Debt-to-Equity Ratio | 75.06 | 98.72 | Teladoc Health Inc. |
| PEG Ratio | -6.16 | -0.87 | Ge Healthcare Technologies Inc. |
| EV/EBITDA | 38.86 | 10.74 | Ge Healthcare Technologies Inc. |
| Profit Margin (TTM) | -7.92% | 10.10% | Ge Healthcare Technologies Inc. |
| Operating Margin (TTM) | -4.20% | 15.73% | Ge Healthcare Technologies Inc. |
| EBITDA Margin (TTM) | N/A | 15.73% | N/A |
| Return on Equity | -13.93% | 22.38% | Ge Healthcare Technologies Inc. |
| Return on Assets (TTM) | -3.20% | 5.47% | Ge Healthcare Technologies Inc. |
| Free Cash Flow (TTM) | $137.33M | $1.51B | Ge Healthcare Technologies Inc. |
| Dividend Yield | N/A | 0.25% | N/A |
| 1-Year Return | 7.00% | -9.79% | Teladoc Health Inc. |
| Price-to-Sales Ratio (TTM) | 0.41 | 1.60 | Teladoc Health Inc. |
| Enterprise Value | $1.28B | $39.12B | Ge Healthcare Technologies Inc. |
| EV/Revenue Ratio | 0.51 | 1.90 | Teladoc Health Inc. |
| Gross Profit Margin (TTM) | 69.32% | 39.68% | Teladoc Health Inc. |
| Revenue per Share (TTM) | $14 | $45 | Ge Healthcare Technologies Inc. |
| Earnings per Share (Diluted) | $-34.20 | $4.55 | Ge Healthcare Technologies Inc. |
| Beta (Stock Volatility) | 2.08 | 1.31 | Ge Healthcare Technologies Inc. |
| Short % of Float | 16.55% | 3.07% | Ge Healthcare Technologies Inc. |
Teladoc Health Inc. vs Ge Healthcare Technologies Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Teladoc Health Inc. | 1.63% | 5.37% | 17.30% | 38.40% | 1.63% | 5.82% |
| Ge Healthcare Technologies Inc. | -0.64% | 0.14% | 6.58% | -10.27% | -23.32% | -21.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Teladoc Health Inc. | 7.00% | -70.52% | -95.30% | -42.92% | -73.79% | -73.79% |
| Ge Healthcare Technologies Inc. | -9.79% | -17.13% | 14.87% | 14.87% | 14.87% | 14.87% |
Performance & Financial Health Analysis: Teladoc Health Inc. vs Ge Healthcare Technologies Inc.
| Metric | TDOC | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.04B | $31.89B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 4,716,750 | 2,502,586 |
| 90 Day Avg. Volume | 4,439,277 | 3,405,145 |
| Last Close | $7.46 | $64.76 |
| 52 Week Range | $4.40 - $9.77 | $58.75 - $89.77 |
| % from 52W High | -23.64% | -27.86% |
| All-Time High | $308.00 (Feb 15, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -97.58% | -31.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.07% |
| Quarterly Earnings Growth | 0.00% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | -0.08% | 0.10% |
| Operating Margin (TTM) | -0.04% | 0.16% |
| Return on Equity (TTM) | -0.14% | 0.22% |
| Debt to Equity (MRQ) | 75.06 | 98.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.77 | $22.77 |
| Cash per Share (MRQ) | $4.38 | $9.86 |
| Operating Cash Flow (TTM) | $294.36M | $1.99B |
| Levered Free Cash Flow (TTM) | $226.14M | $1.69B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.25% |
| Last 12-Month Dividend | N/A | $0.20 |
Valuation & Enterprise Metrics Analysis: Teladoc Health Inc. vs Ge Healthcare Technologies Inc.
| Metric | TDOC (Apr 26, 2026) | GEHC (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 15.92 |
| Forward P/E | -6.16 | 13.02 |
| PEG Ratio | -6.16 | -0.87 |
| Price to Sales (TTM) | 0.41 | 1.60 |
| Price to Book (MRQ) | 0.74 | 3.18 |
| Market Capitalization | ||
| Market Capitalization | $1.04B | $31.89B |
| Enterprise Value | $1.28B | $39.12B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.51 | 1.90 |
| Enterprise to EBITDA | 38.86 | 10.74 |
| Risk & Other Metrics | ||
| Beta | 2.08 | 1.31 |
| Book Value per Share (MRQ) | $7.77 | $22.77 |
Financial Statements Comparison: Teladoc Health Inc. vs Ge Healthcare Technologies Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | TDOC (2025) | GEHC (2025) |
|---|---|---|
| Revenue/Sales | 2.53B | 20.63B |
| Cost of Goods Sold | 771.59M | 12.38B |
| COGS % of Revenue | 30.5% | 60.0% |
| Gross Profit | 1.76B | 8.25B |
| Gross Margin | 69.5% | 40.0% |
| Research & Development | 277.92M | 1.26B |
| Operating Income (EBIT) | -163.40M | 2.76B |
| Operating Margin | -6.5% | 13.4% |
| EBITDA | 260.18M | 3.69B |
| EBITDA Margin | 10.3% | 17.9% |
| Pre-Tax Income | -235.53M | 2.77B |
| Pre-Tax Income % of Revenue | -9.3% | 13.4% |
| Income Tax | -35.21M | 614.00M |
| Income Tax % of Revenue | -1.4% | 3.0% |
| Net Income (Profit) | -200.32M | 2.15B |
| Profit Margin | -7.9% | 10.4% |
Balance Sheet & Liquidity Metrics
| Metric | TDOC (2025) | GEHC (2025) |
|---|---|---|
| Cash & Equivalents | 781.08M | 4.49B |
| Total Current Assets | 1.12B | 12.50B |
| Total Current Assets % of Revenue | 44.2% | 60.6% |
| Total Current Liabilities | 404.74M | 9.11B |
| Total Current Liabilities % of Revenue | 16.0% | 44.1% |
| Long-Term Debt | 1.03B | 9.82B |
| Long-Term Debt % of Revenue | 40.7% | 47.6% |
| Total Shareholders Equity | 1.39B | 10.60B |
| Retained Earnings | -16.43B | 5.28B |
| Retained Earnings % of Revenue | -649.4% | 25.6% |
| Property, Plant & Equipment | 42.03M | 410.00M |
Cash Flow Statement Comparison
| Metric | TDOC (2025) | GEHC (2025) |
|---|---|---|
| Operating Cash Flow | 225.59M | 3.02B |
| Operating Cash Flow % of Revenue | 8.9% | 14.6% |
| Capital Expenditures | N/A | -482.00M |
| Free Cash Flow | 137.33M | 1.51B |
| FCF Margin | 5.4% | 7.3% |
| Debt Repayment | -550.63M | -1.77B |
| Common Stock Repurchase | N/A | -200.00M |
Short Interest & Institutional Ownership Analysis
| Metric | TDOC | GEHC |
|---|---|---|
| Shares Short | 29.71M | 12.36M |
| Short Ratio | 6.89 | 3.20 |
| Short % of Float | 16.55% | 3.07% |
| Shares Outstanding | 178.32M | 455.74M |
| Float Shares | 176.23M | 454.48M |
| % Held by Insiders | 0.65% | 0.35% |
| % Held by Institutions | 75.86% | 93.39% |
| % Held by Public | 23.49% | 6.26% |
Dividend Analysis & Yield Comparison: Teladoc Health Inc. vs Ge Healthcare Technologies Inc.
| Metric | TDOC | GEHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.20 |
| Last 12-Month Dividend Yield | N/A | 0.25% |
| 3-Year Avg Annual Dividend | N/A | $0.15 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | $0.45 |
| Ex-Dividend Date | N/A | Apr 02, 2026 |